|
gptkbp:instanceOf
|
gptkb:cancer
gptkb:disease
|
|
gptkbp:affectsOrgan
|
Liver
|
|
gptkbp:firstDescribed
|
gptkb:Ancient_Egypt
|
|
gptkbp:hasAnnualDeaths
|
Over 700,000 deaths worldwide
|
|
gptkbp:hasAnnualIncidence
|
Over 800,000 cases worldwide
|
|
gptkbp:hasBiomarker
|
Alpha-fetoprotein
|
|
gptkbp:hasDiagnosticMethod
|
Imaging
Biopsy
Blood test
|
|
gptkbp:hasGenderPrevalence
|
More common in males
|
|
gptkbp:hasType
|
gptkb:Hepatocellular_Carcinoma
gptkb:Angiosarcoma
gptkb:Hepatoblastoma
gptkb:Cholangiocarcinoma
|
|
gptkbp:ICD-10_code
|
C22
|
|
gptkbp:medianAge
|
60 years
|
|
gptkbp:mortalityRate
|
High
|
|
gptkbp:prevalence
|
High in East Asia
High in sub-Saharan Africa
|
|
gptkbp:prevention
|
gptkb:Hepatitis_B_vaccination
Maintaining healthy weight
Avoiding alcohol abuse
|
|
gptkbp:prognosis
|
Poor if advanced
|
|
gptkbp:relatedTo
|
Metastatic liver cancer
Primary liver cancer
|
|
gptkbp:riskFactor
|
gptkb:Alcohol_abuse
Diabetes
Obesity
Cirrhosis
Aflatoxin exposure
Hepatitis B infection
Hepatitis C infection
Nonalcoholic fatty liver disease
|
|
gptkbp:stageName
|
gptkb:TNM_staging
Barcelona Clinic Liver Cancer (BCLC)
|
|
gptkbp:symptom
|
gptkb:Nausea
Weight loss
Fatigue
Jaundice
Abdominal pain
Loss of appetite
Ascites
|
|
gptkbp:treatment
|
gptkb:radiation_therapy
gptkb:immunotherapy
Surgery
Chemotherapy
Targeted therapy
Liver transplant
|
|
gptkbp:bfsParent
|
gptkb:D008545
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Liver Cancer
|